Skip to content
components in an Enzyme linked oligonucleotide assay developed by neoaptamers

The Enzyme-Linked Oligonucleotide Assay. The aptamer ELISA.

The Enzyme-Linked Immunosorbent Assay (ELISA) was invented by Swedish scientists Eva Engvall and Peter Perlmann in 1971. This groundbreaking diagnostic method revolutionized medicine by using antibodies to detect the presence of specific hormones or viruses, providing results much faster than traditional methods. The Enzyme-Linked Immunosorbent… Read More »The Enzyme-Linked Oligonucleotide Assay. The aptamer ELISA.

Aptamarkers a biomarker discovery tool

The Aptamarker Platform

Background: By translating information on protein abundance to information on DNA abundance High-Plex proteomics brings deeper analysis than transcriptomics on a protein level. Pioneers like Olink and Somalogic have been leaders in building a future based on protein abundance. There are, however, weaknesses in the… Read More »The Aptamarker Platform

The Importance Of What Is Difficult To Measure

The Importance Of What Is Difficult To Measure: How NeoVentures’ Aptamarker Platform Is Setting New Standards in Protein Measurement

In year three of the French revolution, a law was enacted to realize the rallying cry, “un roi, une loi, un poids, et une mesure” (One king, one law, one weight, and one measure) and this became the introduction of the metric system. The one… Read More »The Importance Of What Is Difficult To Measure: How NeoVentures’ Aptamarker Platform Is Setting New Standards in Protein Measurement

"Scientist in lab coat examining a petri dish sample through a microscope in a laboratory setting.

Unleashing the Potential of Neomer Library: A Revolutionary Approach to Aptamer Characterization and Improvement

In the dynamic realm of molecular biology, the quest for enhancing diagnostic tools and therapeutic approaches is an ever-evolving journey. One significant breakthrough in this pursuit is the development of the Neomer library, an innovative platform that allows the utilization of identical sequences across various… Read More »Unleashing the Potential of Neomer Library: A Revolutionary Approach to Aptamer Characterization and Improvement

Scientist selecting aptamers in a lab.

Aptamarker Use Case: Navigating the Molecular Landscape: Aptamarkers as the Compass for Patient Stratification

Molecular Space Construction: NeoVentures Biotechnology’s Aptamarker platform leverages Aptamarker analysis to construct a molecular space, where individuals cluster based on unique biomolecular profiles. This space captures diversity in responses to diseases and allows for the nuanced exploration of different pathophysiological processes leading to the same… Read More »Aptamarker Use Case: Navigating the Molecular Landscape: Aptamarkers as the Compass for Patient Stratification

Female scientist in a laboratory carefully dispensing liquid into test tubes.

Unleashing the Power of Aptamarkers: A New Frontier in Disease Management

Revolutionary Biomarker Discovery: Aptamarker allows agnostic screening for biomarkers, transforming disease understanding. Enables patient stratification in clinical trials for enhanced safety and precision medicine. Predictive and Precise Drug Development: Predicts side effects and translates animal model findings for safer drug development. Maps drug binding sites… Read More »Unleashing the Power of Aptamarkers: A New Frontier in Disease Management

en_CAEnglish